Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 16.50
+1.00 (6.45%)
At close: Mar 25, 2026
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 22.78 million as of March 25, 2026. Its market cap has increased by 21.90% in one year.
Market Cap
22.78M
Enterprise Value
20.29M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
16.50
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 22.78M, an increase of 162.04%. That is a compound annual growth rate of 4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 22.78M | 10.00% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 49.79M |
| hVIVO | 46.61M |
| Poolbeg Pharma | 29.09M |
| ImmuPharma | 24.63M |
| Arecor Therapeutics | 23.60M |
| SkinBioTherapeutics | 20.34M |
| Aptamer Group | 18.88M |
| Fusion Antibodies | 15.00M |